ライフサイエンスコーパス: hypoplastic left heart syndrome

1 with CHD exist, and these primarily focus on hypoplastic left heart syndrome.

2 t transplant was performed for palliation of hypoplastic left heart syndrome.

3 esults of alternative palliative surgery for hypoplastic left heart syndrome.

4 r atrial septal defects to a high of 28% for hypoplastic left heart syndrome.

5 agement of congenital heart disease, such as hypoplastic left heart syndrome.

6 notypes, including the first mouse models of hypoplastic left heart syndrome.

7 unction, or interstage AVVR in children with hypoplastic left heart syndrome.

8 tients undergoing first-stage palliation for hypoplastic left heart syndrome.

9 y for critical aortic stenosis with evolving hypoplastic left heart syndrome.

10 d function, possibly preventing evolution to hypoplastic left heart syndrome.

11 al of an alternative management strategy for hypoplastic left heart syndrome.

12 in cases of congenital heart disease such as hypoplastic left heart syndrome.

13 y improved the survival of infants born with hypoplastic left heart syndrome.

14 equiring intervention, to severe, as seen in hypoplastic left heart syndrome.

15 ormal mitral valve, aortic root dilation, or hypoplastic left heart syndrome.

16 for single-ventricle defects, in particular, hypoplastic left heart syndrome.

17 rt diseases of heterogeneous origin, such as hypoplastic left heart syndrome.

18 made in the treatment of children born with hypoplastic left heart syndrome.

19 ants together under the unsatisfactory term "hypoplastic left heart syndrome."

20 ubtypes were associated with smaller HC, eg, hypoplastic left heart syndrome, -0.39 (95% CI, -0.58 to

21 heart obstructive lesions, including 19 with hypoplastic left heart syndrome, 3 with critical aortic

22 Five-year survival varied by defect type: hypoplastic left heart syndrome, 38.0% (95% confidence i

23 Diagnoses were hypoplastic left heart syndrome (66%), other congenital

24 The rarest CHD found was hypoplastic left heart syndrome, a phenotype never seen

25 and suitable for follow-up of patients with hypoplastic left heart syndrome after Fontan palliation.

26 Hypoplastic left heart syndrome anatomic subtype did not

27 Infants born with hypoplastic left heart syndrome and an intact or highly

28 al defect for the treatment of neonates with hypoplastic left heart syndrome and an intact or restric

29 microdeletions of FOXF1 were associated with hypoplastic left heart syndrome and gastrointestinal atr

30 and improvement of outcomes in fetuses with hypoplastic left heart syndrome and intact atrial septum

31 s to investigate the outcome in infants with hypoplastic left heart syndrome and intact atrial septum

32 intervention, outcome for infants born with hypoplastic left heart syndrome and intact atrial septum

33 en fetuses at 26 to 34 weeks' gestation with hypoplastic left heart syndrome and intact or highly res

34 A diagnosis of hypoplastic left heart syndrome and longer operative sup

35 bstructions and nitrogen dioxide and between hypoplastic left heart syndrome and particulate matter w

36 o, the progress in the 3-stage palliation of hypoplastic left heart syndrome and related single right

37 ll 5-year survival, particularly in cases of hypoplastic left heart syndrome and single ventricle.

38 in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome and, in a subset of case

39 the great arteries, interrupted aortic arch, hypoplastic left heart syndrome, and aortic coarctation,

40 cantly higher ORs for atrial septal defects, hypoplastic left heart syndrome, aortic stenosis, pulmon

41 Patients with hypoplastic left heart syndrome are at higher risk of fa

42 ring 3-stage single-ventricle palliation for hypoplastic left heart syndrome, attrition after the Nor

43 culate matter was positively associated with hypoplastic left heart syndrome but inversely associated

44 First-stage palliation of hypoplastic left heart syndrome has been performed as a

45 Surgical management of hypoplastic left heart syndrome has changed the prognosi

46 h dominant right ventricle (66% vs. 36%) and hypoplastic left heart syndrome (HLHS) (47% vs. 13%).

47 ience with staged reconstructive surgery for hypoplastic left heart syndrome (HLHS) and assess curren

48 dy was designed to identify disease loci for hypoplastic left heart syndrome (HLHS) and evaluate the

49 is (AVS), coarctation of the aorta (COA) and hypoplastic left heart syndrome (HLHS) are congenital ca

50 Outcome of stage 1 palliation (S1P) for hypoplastic left heart syndrome (HLHS) has improved coin

51 oppler (PVD) flow patterns in the fetus with hypoplastic left heart syndrome (HLHS) have been correla

52 Results of staged palliation for hypoplastic left heart syndrome (HLHS) have improved in

53 ent strategies for preoperative infants with hypoplastic left heart syndrome (HLHS) include increased

54 Hypoplastic left heart syndrome (HLHS) is a fatal congen

55 Hypoplastic left heart syndrome (HLHS) is a severe cardi

56 Hypoplastic left heart syndrome (HLHS) is among the most

57 y blood flow after the Norwood operation for hypoplastic left heart syndrome (HLHS) is critical to ea

58 Hypoplastic left heart syndrome (HLHS) is frequently dia

59 t (heritability) in families identified by a hypoplastic left heart syndrome (HLHS) proband.

60 progression of fetal aortic stenosis (AS) to hypoplastic left heart syndrome (HLHS) requires identifi

61 icuspid valve regurgitation in children with hypoplastic left heart syndrome (HLHS) undergoing staged

62 ined risk factors for one-year mortality for hypoplastic left heart syndrome (HLHS) using intention-t

63 Hypoplastic left heart syndrome (HLHS) with intact or ve

64 mmune model of structural CHD that resembles hypoplastic left heart syndrome (HLHS), a life-threateni

65 Here, we show that hypoplastic left heart syndrome (HLHS), a severe CHD, is

66 lvotomy, shunt type in staged palliation for hypoplastic left heart syndrome (HLHS), and strategies f

67 The first stage of surgical palliation of hypoplastic left heart syndrome (HLHS), the NO, includes

68 of patients with post-stage I palliation for hypoplastic left heart syndrome (HLHS).

69 critical congenital heart disease, including hypoplastic left heart syndrome (HLHS).

70 osis in an attempt to prevent progression to hypoplastic left heart syndrome (HLHS).

71 pulmonary connection (TCPC) in children with hypoplastic left heart syndrome (HLHS).

72 stic approach, management, and outcomes than hypoplastic left heart syndrome (HLHS).

73 including an unprecedented high frequency of hypoplastic left heart syndrome (HLHS).

74 event progression of aortic stenosis (AS) to hypoplastic left heart syndrome (HLHS).

75 egurgitation after staged reconstruction for hypoplastic left heart syndrome (HLHS).

76 identify the optimal treatment strategy for hypoplastic left heart syndrome (HLHS).

77 ho have undergone reconstructive surgery for hypoplastic left heart syndrome (HLHS).

78 ntan pleural drainage (HR, 4.0; P<0.001) and hypoplastic left heart syndrome (HR, 2.0; P=0.01).

79 protocols and a home surveillance system for hypoplastic left heart syndrome improves outcomes.

80 The proportion with hypoplastic left heart syndrome increased from 1/173 (1%

81 Hypoplastic left heart syndrome is a rare congenital hea

82 Hypoplastic left heart syndrome is a severe form of card

83 t ventricular (RV) function in patients with hypoplastic left heart syndrome is important during long

84 "Hypoplastic left heart syndrome" is an unsatisfactory te

85 Fifty-two patients with hypoplastic left heart syndrome (median age, 6.6; range

86 fetal diagnosis of aortic stenosis/evolving hypoplastic left heart syndrome, more than twice as many

87 6) palliation of tricuspid atresia (n = 13), hypoplastic left heart syndrome (n = 10) or other forms

88 TGA) (n = 69), tetralogy of Fallot (n = 66), hypoplastic left heart syndrome (n = 51), and coarctatio

89 Diagnoses were hypoplastic left heart syndrome (n=346), tricuspid atres

90 The most common diagnosis was hypoplastic left heart syndrome (n=80, 36.7%).

91 o with the modified Blalock-Taussig shunt in hypoplastic left heart syndrome or variants is currently

92 eration (P=0.002), the anatomic diagnoses of hypoplastic left heart syndrome (P<0.001) and "other com

93 achievement scores included the diagnoses of hypoplastic left heart syndrome (P=0.004) and "other com

94 um atrial septal defect, aortic coarctation, hypoplastic left heart syndrome, patent ductus arteriosu

95 ation-derived indices of RV contractility in hypoplastic left heart syndrome patients after Fontan pa

96 orwood, Sano, and Hybrid, currently used for hypoplastic left heart syndrome pose a risk of myocardia

97 Patients with hypoplastic left heart syndrome, pulmonary atresia intac

98 progressive improvement in surgical results, hypoplastic left heart syndrome remains one of the conge

99 Their role in management of hypoplastic left heart syndrome remains to be defined, e

100 Of 316 infants with hypoplastic left heart syndrome seen at our center over

101 In the hypoplastic left heart syndrome, severe restriction at t

102 oplasty; shunt type in staged palliation for hypoplastic left heart syndrome; strategies for SCP.

103 m from failure was 79% (95% CI, 61%-89%) for hypoplastic left heart syndrome versus 92% (95% CI, 87%-

104 Hypoplastic left heart syndrome was the primary predicto

105 Infants with hypoplastic left heart syndrome were smaller in all meas

106 ted left ventricle predictably progresses to hypoplastic left heart syndrome when associated with cer

107 cular repair surgery in infant patients with hypoplastic left heart syndrome, where surgical removal

108 the following hypotheses: (1) patients with hypoplastic left heart syndrome who develop significant

109 cal data were reviewed for 138 children with hypoplastic left heart syndrome who underwent stage I su

110 rid approach achieves stage 1 palliation for hypoplastic left heart syndrome with different flow char